Analytical Data
-
Gene name
AFAP1
- Application
-
Alternative Names
AFAP-110; 110 kDa actin filament-associated protein
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q80YS6
-
Expression Region
Cys352~Glu572
-
Molecular Weight
28kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AFAP1 (Actin Filament Associated Protein 1) is a crucial protein involved in regulating the organization of the actin cytoskeleton, which is essential for various cellular processes such as migration, adhesion, and division. Research has indicated that AFAP1 plays a significant role in cellular signaling pathways, particularly in cancer biology, where its expression levels can influence tumor progression and metastasis. Recent studies have focused on the recombinant expression of AFAP1 to better understand its function and interaction with other cytoskeletal proteins. By creating and analyzing AFAP1 recombinant proteins, researchers aim to elucidate its structural properties and dynamic behavior within cells. Understanding the role of AFAP1 in cellular mechanisms could provide insights into potential therapeutic targets for diseases characterized by cytoskeletal dysfunction. This growing body of research emphasizes the need for detailed investigation into the molecular mechanisms of AFAP1, facilitating a clearer understanding of its contributions to normal physiology and pathological conditions.
